ORNL produces and supplies actinium-225, a rare isotope essential for targeted alpha therapy and vital to advancing cancer treatment research. Targeted alpha therapy attacks tumors while sparing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results